NCT00660699 2015-05-27A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersWashington University School of MedicinePhase 2 Completed50 enrolled 21 charts